These effects, together with a previous report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the thought of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Problems.The similarity among a pair of medicine was c